It is to track what changes, what does not, and how any sourcing or protocol decision was made
The length of time alcohol stays in the body will depend on factors such as individual features, how much a person has drunk, and how quickly they consumed the beverage
Related topics More weekend picks Published3 January Published21 December 2025
Among these NAEs, exenatide accounted for 10,175 cases (35.14%), liraglutide for 3,686 cases (12.73%), lixisenatide for 256 cases (0.88%), dulaglutide for 6,034 cases (20.84%), semaglutide for 5,935 cases (20.50%), and tirzepatide for 2,867 cases (9.90%)
Confirm your vial size
17 Moreover, other trials as the SUSTAIN-6 trial showed that semaglutide, another GLP-1RA also reduced the risk of MACE by 26% and non-fatal stroke by 39% in patients with T2DM